BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7535009)

  • 1. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia.
    Myers PR; Zhong Q; Jones JJ; Tanner MA; Adams HR; Parker JL
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H955-61. PubMed ID: 7535009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia.
    Parker JL; Myers PR; Zhong Q; Kim K; Adams HR
    Shock; 1994 Dec; 2(6):451-8. PubMed ID: 7538038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
    Myers PR; Wright TF; Tanner MA; Adams HR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia.
    Parker JL; Adams HR
    Circ Res; 1993 Mar; 72(3):539-51. PubMed ID: 7679334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced prostanoid-mediated vasorelaxation in pulmonary arteries isolated during experimental endotoxemia.
    Myers TP; Myers PR; Adams HR; Parker JL
    Shock; 1999 Jun; 11(6):436-42. PubMed ID: 10454834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells.
    Graier WF; Myers PR; Rubin LJ; Adams HR; Parker JL
    Circ Res; 1994 Oct; 75(4):659-68. PubMed ID: 7923612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Parker JL; Tanner MA; Adams HR
    Shock; 1994 Jan; 1(1):73-8. PubMed ID: 7743332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli endotoxemia alters coronary and pulmonary arteriolar responses to platelet products.
    Sellke FW; Wang SY; VanderMeer TJ; Fink MP
    Shock; 1994 Apr; 1(4):279-85. PubMed ID: 7735962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta.
    Hutcheson IR; Griffith TM
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H590-6. PubMed ID: 7511348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived relaxing factor: presence in pulmonary and systemic arteries of the newborn guinea pig.
    Davidson D; Eldemerdash A
    Pediatr Res; 1990 Feb; 27(2):128-32. PubMed ID: 2107513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.
    Cappelli-Bigazzi M; Battaglia C; Pannain S; Chiariello M; Ambrosio G
    J Mol Cell Cardiol; 1997 Mar; 29(3):871-9. PubMed ID: 9152848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of endothelium-derived relaxing factor from resistance arteries in hypertension.
    Angus JA; Dyke AC; Jennings GL; Korner PI; Sudhir K; Ward JE; Wright CE
    Kidney Int Suppl; 1992 Jun; 37():S73-8. PubMed ID: 1378518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta.
    Umans JG; Wylam ME; Samsel RW; Edwards J; Schumacker PT
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1638-45. PubMed ID: 8256913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-derived relaxant factor inhibits effects of nitrocompounds in isolated arteries.
    Pohl U; Busse R
    Am J Physiol; 1987 Feb; 252(2 Pt 2):H307-13. PubMed ID: 3492925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.
    Förstermann U; Pollock JS; Schmidt HH; Heller M; Murad F
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1788-92. PubMed ID: 1705708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF.
    Guerra R; Brotherton AF; Goodwin PJ; Clark CR; Armstrong ML; Harrison DG
    Blood Vessels; 1989; 26(5):300-14. PubMed ID: 2576820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis increases NOS-2 activity and decreases non-NOS-mediated acetylcholine-induced dilation in rat aorta.
    Beach PK; Spain DA; Kawabe T; Harris PD; Garrison RN
    J Surg Res; 2001 Mar; 96(1):17-22. PubMed ID: 11180991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.